Related Experiment Video
Updated: Jul 30, 2026
10:10
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Thermal behaviour and dissolution properties of phenylbutazone polymorphs
The Journal of Pharmacy and Pharmacology
|April 1, 1983
Summary
Phenylbutazone polymorphs interconvert, especially at slower heating rates or upon grinding, impacting dissolution behavior. The Berthoud model accurately describes dissolution, influenced by tablet excipients.
Area of Science:
- Pharmaceutical Sciences
- Solid-State Chemistry
Background:
- Polymorphism significantly affects drug properties like solubility and bioavailability.
- Understanding phenylbutazone's solid-state behavior is crucial for formulation development.
Purpose of the Study:
- To prepare and characterize phenylbutazone polymorphs.
- To investigate their interconversion behavior.
- To evaluate dissolution characteristics and the applicability of the Berthoud model.
Main Methods:
- Differential scanning calorimetry (D.S.C.) for thermal analysis.
- Preparation and characterization of five phenylbutazone polymorphic forms.
- Equilibrium solubility and intrinsic dissolution rate measurements.
Main Results:
- Observed interconversion of three polymorphs to a more stable form under specific conditions (slow heating, grinding).
- Dissolution process successfully modeled using the Berthoud equation.
- Identified influence of tablet excipients on dissolution.
Conclusions:
- Phenylbutazone exhibits polymorphic interconversion, affecting its solid-state properties.
- The Berthoud model is suitable for describing phenylbutazone dissolution.
- Excipients play a role in the dissolution performance of phenylbutazone formulations.
Related Concept Videos
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
01:27Factors Influencing Drug Absorption: Drug Dissolution
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...